About
Prenostics develops a blood test technology that detects cancer at its earliest stages (stages 0-2), focusing initially on ovarian cancer and lung nodules to enable earlier diagnosis and treatment.
Explore Prenostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.